47. Research and development expenses For the year ended 31 March 2023 31 March 2022 Capital expenditure 0.07 0.92 Revenue expenditure 10.81 8.07 Total 10.88 8.99 48. Disclosure under Micro, Small and Medium Enterprises Development Act, 2006 The creditors covered by Micro, Small and Medium Enterprises Development Act, 2006 (“the MSMED Act, 2006”) have been identifi ed on the basis of information available with the Company. The auditors have placed reliance on the information provided by the management. Disclosures in respect of the amounts payable to such parties are given below: As at 31 March 2023 31 March 2022 (i) The principal amount remaining unpaid as at the end of the year. 61.23 77.02 (ii) The amount of interest accrued and remaining unpaid on (i) above. - - (iii) Amount of interest paid by the Company in terms of Section 16, of the MSMED Act, 2006 along with the amounts of payments made beyond the appointed date during the year. - - (iv) The amount of interest due and payable for the period (where the principal has been paid but interest under the MSMED Act, 2006 not paid) - - (v) The amount of further interest remaining due and payable in the succeeding years, until such date when the interest dues as above are actually paid to the small enterprises for the purpose of disallowance as a deductible expenditure under Section 23 of the MSMED Act, 2006. - - Notes: Explanation - The terms ‘appointed day,’ ‘buyer,’ ‘enterprise,’ ‘micro enterprise,’ ‘small enterprise’ and ‘supplier ’ shall have the same meaning as assigned to them under clauses (b),(d),( e), (h), (m) and (n) respectively of section 2 of the Micro, Small and Medium Enterprises Development Act, 2006. 49. Government grant For the year ended 31 March 2023 31 March 2022 Opening liability 93.02 27.12 Received during the year - 73.26 Released to the statement of profi t and loss (6.74) (7.36) Closing liability 86.28 93.02 Current 6.73 6.74 Non-current 79.55 86.28 (*) Government grant has been received for purchase of certain items of Property, plant and equipment. There are no unfulfi lled conditions or contingencies attached to these grants. Summary of the significant accounting policies and other explanatory information (All amounts in ` millions, except share data and where otherwise stated) 241 Standalone | Financial Statements
RkJQdWJsaXNoZXIy NTE5NzY=